Comparison of progestin-primed ovarian stimulation regimen and antagonist regimen in women aged 35 years or older with diminished ovarian reserve: A propensity score-matched study.

Autor: Wang M; Prenatal Diagnosis Center, Reproductive Medicine Center, The First Hospital of Jilin University, Changchun, Jilin, China., Li L; Prenatal Diagnosis Center, Reproductive Medicine Center, The First Hospital of Jilin University, Changchun, Jilin, China., Zhu H; Prenatal Diagnosis Center, Reproductive Medicine Center, The First Hospital of Jilin University, Changchun, Jilin, China., Wang R; Prenatal Diagnosis Center, Reproductive Medicine Center, The First Hospital of Jilin University, Changchun, Jilin, China., Liu R; Prenatal Diagnosis Center, Reproductive Medicine Center, The First Hospital of Jilin University, Changchun, Jilin, China., Zhang H; Prenatal Diagnosis Center, Reproductive Medicine Center, The First Hospital of Jilin University, Changchun, Jilin, China.
Jazyk: angličtina
Zdroj: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics [Int J Gynaecol Obstet] 2024 Oct; Vol. 167 (1), pp. 162-168. Date of Electronic Publication: 2024 Apr 15.
DOI: 10.1002/ijgo.15543
Abstrakt: Objective: Diminished ovarian reserve (DOR) has been a major challenge in infertility treatment. The present study aimed to compare the efficacy of progestin-primed ovarian stimulation (PPOS) regimen and antagonist regimen in infertile patients aged 35 years or older with DOR.
Methods: A retrospective study of 289 in vitro fertilization (IVF) cycles from April 2016 to June 2022 was performed. Propensity score matching (PSM) was used to balance the baseline characteristics between the two groups at a ratio of 1:1.
Results: After matching, there were 87 cycles in the PPOS group and 87 cycles in the antagonist group. The primary outcome measures included the incidence of premature LH surge, the number of retrieved oocytes, and the number of mature oocytes, which were comparable between the two groups (all P values >0.05). There were no significant differences in laboratory indicators and final clinical outcomes between the two groups (all P values >0.05).
Conclusions: For DOR patients aged 35 years or older, the number of retrieved oocytes and the number of mature oocytes were comparable between the PPOS and antagonist groups. Moreover, the two regimens showed no difference in the inhibition of premature LH surge.
(© 2024 The Authors. International Journal of Gynecology & Obstetrics published by John Wiley & Sons Ltd on behalf of International Federation of Gynecology and Obstetrics.)
Databáze: MEDLINE
Externí odkaz: